The biosynthesis of prostaglandins and leukotrienes proceeds through the formation of chemically reactive intermediates leukotriene A 4 (LTA 4 ) and prostaglandin H 2 (PGH 2 ) which in aqueous solutions have chemical half-lives of 3 s and 3 min, respectively. Prostacyclin (PGI 2 ) is another chemically reactive prostanoid that has a chemical half-life of 3-4 min. The recent development of reversed phase HPLC stationary phases that are stable to elevated pH (pH 10 -12) without significant column damage has permitted direct analysis of these acid-sensitive eicosanoids. Using electrospray ionization, molecular anions [M Ϫ H] Ϫ of these compounds were observed at m/z 317 for LTA 4 and m/z 351 for both PGH 2 and PGI 2 . The mechanism of formation of ions derived from collisional activation of LTA 4 was studied using stable isotope labeled and chemical analogs of LTA 4 and found to involve formation of highly conjugated anions at m/z 261 and 163. The collisional activation of the molecular anion of PGH 2 yielded a product ion spectrum identical to that observed for the isomeric prostaglandins PGE 2 and PGD 2 . However, it was possible to baseline separate PGE 2 , PDG 2 , and PGH 2 by reversed phase HPLC using basic HPLC mobile phases. The collisional activation of PGI 2 led to a family of abundant ions including highly conjugated carbon-centered and oxygen-centered radical species (m/z 245 and 205) likely derived from the attack of the carboxylate anion on the cyclic enolether of PGI 2 as well as the most abundant product ion (m/z 215) which formed following loss of neutral hexanal and water. The structures of these product ions were consistent with high resolution measurements measured in a quadrupole time-of-flight mass
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.